Diabetes used to be a death sentence, killing people by disrupting sugar metabolism. But in 1922, University of Toronto researchers and physicians successfully treated a boy with diabetes by injecting him with insulin extracted from animal pancreases. Physicians clamored for the new drug, so the university began collaborating with Eli Lilly and Company to satisfy the demand. The company refined and scaled up production techniques and delivered the world’s first commercial doses in 1923. The American Chemical Society honored Lilly’s role in these achievements with a National Historic Chemical Landmark designation ceremony in Indianapolis on March 27. Speakers at the event included ACS president-elect Mary Carroll and Leonard Glass, senior vice president of Lilly diabetes global medical affairs. “The global pandemic has demonstrated unambiguously that science matters,” Carroll said. “It has shown the critical importance of performing and publishing rigorous scientific work, educating students, and communicating science to elected officials